CXCR3 and neoplasm: Thus, the authors evaluated the impact of neutralizing antibodies for IFNγ and CXCR3 on T-BsAb efficacy and showed that both antibodies were able to inhibit T cell recruitment into tumors and attenuate the inhibition of tumor growth by T-BsAb.